Physician profile
Alejandro J Lopez Mas
NPI 1043487960
$142,184.06
in general payments reported to CMS, 2019-2025
26 companies · $7,003 in 2025
The $7,003 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $21K · 2021: $15K · 2022: $22K · 2023: $19K · 2024: $23K · 2025: $7,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $7,936 · Travel and Lodging: $1,504 · Consulting Fee: $900 · Education: $4.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,161.75 |
| Food and Beverage | $7,936.25 |
| Travel and Lodging | $1,503.54 |
| Consulting Fee | $900.00 |
| Education | $4.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $60,014.43 | 2019-2025 | Eliquis, Camzyos |
| Pfizer Pharmaceuticals LLC | $25,779.54 | 2019-2020 | |
| Boston Scientific Corporation | $23,203.30 | 2019-2025 | Rotapro, Avvigo Guidance System, Synergy |
| Astrazeneca Pharmaceuticals Lp | $8,307.66 | 2019-2025 | Lokelma, Farxiga, Brilinta |
| Pfizer INC. | $7,647.68 | 2021-2025 | |
| Edwards Lifesciences Corporation | $5,334.25 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $4,613.83 | 2019-2024 | Xarelto |
| Medtronic, INC. | $1,461.98 | 2019-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,394.56 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $804.25 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $731.62 | 2021-2025 | |
| Abbott Laboratories | $722.18 | 2019-2023 | Mitraclip, Jot Dx, Amplatzer Talisman |
| Amgen INC. | $663.73 | 2019-2025 | Krystexxa, Repatha, Repatha |
| Pbg Puerto Rico LLC | $509.49 | 2019-2025 | |
| Bayer Puerto Rico INC. | $234.29 | 2023-2025 | Kerendia |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $178.16 | 2025 | |
| Merck Sharp & Dohme LLC | $152.53 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $97.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $88.26 | 2021-2024 | |
| Abiomed | $78.42 | 2023 | Impella |
| Medtronic Vascular, INC. | $60.48 | 2019-2020 | |
| Johnson and Johnson International | $31.86 | 2021 | |
| Terumo Medical Corporation | $25.93 | 2025 | Angio-Seal |
| Angiodynamics, INC. | $22.53 | 2020 | |
| Cardinal Health P.R. 120 INC | $12.84 | 2021 | |
| Cordis US Corp. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Lopez Mas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.